Peak Pharmaceuticals, Inc. operates as a biopharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THCfree, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryCannabis
SectorMedical
CIKN/A
Phone480-659-6404
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1
Next Earnings DateN/A
OptionableNot Optionable
Peak Pharmaceuticals (OTCMKTS:PKPH) Frequently Asked Questions
What is Peak Pharmaceuticals' stock symbol?
Peak Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PKPH."
Has Peak Pharmaceuticals been receiving favorable news coverage?
Media stories about PKPH stock have trended neutral on Sunday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Peak Pharmaceuticals earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Peak Pharmaceuticals' key competitors?
Some companies that are related to Peak Pharmaceuticals include Adial Pharmaceuticals (ADIL), GTX (GTXI), Heat Biologics (HTBX), Aileron Therapeutics (ALRN), Q BioMed (QBIO), Acerus Pharmaceuticals (TRLPF), RegeneRx Biopharmaceuticals (RGRX), Genprex (GNPX), SUMMIT THERAPEU/S (SMMT), IMMURON LTD/S (IMRN), Evoke Pharma (EVOK), Fibrocell Science (FCSC), Onconova Therapeutics (ONTX), Citius Pharmaceuticals (CTXR) and Ceapro (CRPOF).
What other stocks do shareholders of Peak Pharmaceuticals own?
Who are Peak Pharmaceuticals' key executives?
Peak Pharmaceuticals' management team includes the folowing people:
- Mr. Neil T. Reithinger, CEO, Pres, CFO, Principal Accounting Officer, Treasurer, Sec. & Director (Age 49)
How do I buy shares of Peak Pharmaceuticals?
Shares of PKPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Peak Pharmaceuticals' stock price today?
One share of PKPH stock can currently be purchased for approximately $0.0950.
How big of a company is Peak Pharmaceuticals?
Peak Pharmaceuticals has a market capitalization of $7.44 million. Peak Pharmaceuticals employs 1 workers across the globe.
What is Peak Pharmaceuticals' official website?
How can I contact Peak Pharmaceuticals?
Peak Pharmaceuticals' mailing address is 14201 N. HAYDEN ROAD SUITE A-1, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-659-6404 or via email at [email protected]
MarketBeat Community Rating for Peak Pharmaceuticals (OTCMKTS PKPH)
MarketBeat's community ratings are surveys of what our community members think about Peak Pharmaceuticals and other stocks. Vote "Outperform" if you believe PKPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PKPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
